GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Tekla Healthcare Opportunities Fund (NYSE:THQ) » Definitions » ROA %

Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) ROA % : -1.61% (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is Tekla Healthcare Opportunities Fund ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Tekla Healthcare Opportunities Fund's annualized Net Income for the quarter that ended in Sep. 2023 was $-17.46 Mil. Tekla Healthcare Opportunities Fund's average Total Assets over the quarter that ended in Sep. 2023 was $1,081.34 Mil. Therefore, Tekla Healthcare Opportunities Fund's annualized ROA % for the quarter that ended in Sep. 2023 was -1.61%.

The historical rank and industry rank for Tekla Healthcare Opportunities Fund's ROA % or its related term are showing as below:

THQ' s ROA % Range Over the Past 10 Years
Min: -7.48   Med: 8.57   Max: 16.59
Current: 4.9

During the past 7 years, Tekla Healthcare Opportunities Fund's highest ROA % was 16.59%. The lowest was -7.48%. And the median was 8.57%.

THQ's ROA % is ranked better than
61.41% of 1713 companies
in the Asset Management industry
Industry Median: 2.86 vs THQ: 4.90

Tekla Healthcare Opportunities Fund ROA % Historical Data

The historical data trend for Tekla Healthcare Opportunities Fund's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tekla Healthcare Opportunities Fund ROA % Chart

Tekla Healthcare Opportunities Fund Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
ROA %
Get a 7-Day Free Trial -3.94 11.02 16.59 -7.48 4.96

Tekla Healthcare Opportunities Fund Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.48 6.04 -21.60 11.36 -1.61

Competitive Comparison of Tekla Healthcare Opportunities Fund's ROA %

For the Asset Management subindustry, Tekla Healthcare Opportunities Fund's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tekla Healthcare Opportunities Fund's ROA % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Tekla Healthcare Opportunities Fund's ROA % distribution charts can be found below:

* The bar in red indicates where Tekla Healthcare Opportunities Fund's ROA % falls into.



Tekla Healthcare Opportunities Fund ROA % Calculation

Tekla Healthcare Opportunities Fund's annualized ROA % for the fiscal year that ended in Sep. 2023 is calculated as:

ROA %=Net Income (A: Sep. 2023 )/( (Total Assets (A: Sep. 2022 )+Total Assets (A: Sep. 2023 ))/ count )
=52.786/( (1066.014+1062.061)/ 2 )
=52.786/1064.0375
=4.96 %

Tekla Healthcare Opportunities Fund's annualized ROA % for the quarter that ended in Sep. 2023 is calculated as:

ROA %=Net Income (Q: Sep. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=-17.458/( (1100.61+1062.061)/ 2 )
=-17.458/1081.3355
=-1.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Sep. 2023) net income data. ROA % is displayed in the 30-year financial page.


Tekla Healthcare Opportunities Fund  (NYSE:THQ) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2023 )
=Net Income/Total Assets
=-17.458/1081.3355
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-17.458 / -15.664)*(-15.664 / 1081.3355)
=Net Margin %*Asset Turnover
=111.45 %*-0.0145
=-1.61 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) net income data. The Revenue data used here is two times the semi-annual (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Tekla Healthcare Opportunities Fund ROA % Related Terms

Thank you for viewing the detailed overview of Tekla Healthcare Opportunities Fund's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Business Description

Traded in Other Exchanges
N/A
Address
1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.
Executives
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy officer: Secretary and Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103

Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Headlines